Innovation through telemedicine to improve medication abortion access in primary health centers: findings from a pilot study in Musanze District, Rwanda [PDF]
BMC Public HealthIn 2012 Rwanda expanded legal grounds for abortion to include cases of rape, incest, forced marriage, the health of a pregnant person or fetus at risk, and for minors on request in 2018.
Ndola Prata +7 more
doaj +3 more sources
No-Test Screening Protocols May Disproportionately Exclude Structurally Oppressed Communities Who Could Benefit from Accessing Medication Abortion [PDF]
Health EquityObjective: To explore disparities in ineligibility for medication abortion using no-test screening criteria compared with assessment with testing including ultrasound.
M. Antonia Biggs +12 more
doaj +3 more sources
Aya Contigo: evaluation of a digital intervention to support self-managed medication abortion in Venezuela [PDF]
Frontiers in Global Women's HealthBackgroundVenezuela continues to face a humanitarian crisis, where healthcare is difficult to access and abortion is legally restricted. In response to a growing need for life-saving abortion and sexual and reproductive health (SRH) services, a digital ...
Kathryn Cleverley +6 more
doaj +3 more sources
Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study [PDF]
BMC Women's HealthBackground This qualitative study aims to assess perspectives of clinicians and clinic staff on mail-order pharmacy dispensing for medication abortion.
Sarah Raifman +6 more
doaj +3 more sources
PLoS ONE, 2023 In this study we explored nurse practitioner-provided medication abortion in Canada and identified barriers and enablers to uptake and implementation. Between 2020–2021, we conducted 43 semi-structured interviews with 20 healthcare stakeholders and 23 ...
Andrea Carson +7 more
doaj +3 more sources
Exploring pharmacy provision of medication abortion pills in Nepal: a mixed-methods study of pharmacy workers’ knowledge and practices [PDF]
Sexual and Reproductive Health MattersIn Nepal, pharmacists are legally permitted to dispense medication abortion drugs with a prescription but provision of mifepristone/misoprostol without a prescription is prohibited. However, one in five Nepalese women seeking medication abortion pills do
Nished Rijal, Angel M. Foster
doaj +2 more sources
A qualitative analysis of pharmacists’ attitudes towards provision of medication abortion
BMC Health Services Research, 2023 Background 90% of United States’ counties do not have a single clinic offering abortion care, and barriers to care disproportionately affect low-income families.
Selina Sandoval +5 more
doaj +2 more sources
The Role of Medication Abortion Provision in US States Without Total Abortion Bans, 2023. [PDF]
Perspect Sex Reprod HealthBackground Medication abortion has accounted for an increasing share of abortions in the United States (US) since the Food and Drug Administration's approval of mifepristone in 2000.
DoCampo I, Jones RK, Maddow-Zimet I.
europepmc +2 more sources
Exploring the availability and accessibility of medication abortion pills without a prescription: a mystery client study of pharmacies in Mumbai, India [PDF]
BMC Public HealthBackground In India, mifepristone was introduced in 2002 for use with misoprostol as medication abortion and is currently approved for use up to nine weeks of gestation.
Dipesh Suvarna +4 more
doaj +2 more sources
Who pays more? Exploring cost disparities in medication abortion access across socio-demographic groups in Ghana. [PDF]
Int J Equity HealthMedication abortion (MA) may be accessed covertly in private pharmacies and clinics due to abortion-related stigma. Stigmatization may lead to information asymmetry, resulting in price discrimination.
Agula C +7 more
europepmc +2 more sources